latest outbreak ebola virus disease west africa monoclonal antibody therapy eg map until treat patient howe due antigen differ among five ebolaviru spec current therapeutic antibody effect virus air although particular index caps major human infect central recent sudan bundibugyo also repeatedly outbreak thu neglect develop countermeasures ebolavirus report genre glycoproteinspecif effect inhibit cellular entry metres iso known vitro show protect efficacy mouse model novel neutral target highly conserve intern fusion loop glycoprotein molecule prevent membrane viral envelope membrane discovery crossneutr provide promise option broadcast accuser design improv vaccine select elicit multiple 